LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment

19.03.2019|Press Releases|

LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma A/S, a global leader in dermatology, today announced that the companies will start the clinical trial of microarray patches for the local intradermal treatment of psoriasis.

LTS AG donates a new pediatric anaesthesia trolley to the St. Nikolaus-Stifts Hospital in Andernach.

4.02.2019|Press Releases|

In January members of the Association, along with Dr. Torsten Baehner, head physician of the Anaesthesia and IC unit at St. Nikolaus-Stift Hospital, displayed the trolley for Ulrich Sielaff, member of the board at LTS.

Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson’s Disease

12.03.2018|Company News|

Initial results of the market analysis indicate there is a substantial market for AP-CD/LD to potentially serve hundreds of thousands of patients suffering with Parkinson's Disease.

End-to-end monitoring assures drug safety: LTS progresses in drug serialization

5.05.2017|Company News|

About 10 % of all pharmaceuticals worldwide are suspected to be counterfeited. This may have led to the death of possibly up to 70.000 patients using tuberculosis- and malaria remedies alone, the safety of pharmaceuticals patients had fatally relied upon. LTS supports the global battle against counterfeiting of pharmaceuticals.

Go to Top